APA (7th ed.) Citation

RP, E., J, B., DO, W., YY, C., J, M., J, A., . . . SL, W. (2017). 45 Gy is not sufficient radiotherapy dose for Group III orbital embryonal rhabdomyosarcoma after less than complete response to 12 weeks of ARST0331 chemotherapy: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group. Pediatric blood & cancer, 64(9), . https://doi.org/10.1002/pbc.26540

Chicago Style (17th ed.) Citation

RP, Ermoian, et al. "45 Gy Is Not Sufficient Radiotherapy Dose for Group III Orbital Embryonal Rhabdomyosarcoma After Less than Complete Response to 12 Weeks of ARST0331 Chemotherapy: A Report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group." Pediatric Blood & Cancer 64, no. 9 (2017). https://doi.org/10.1002/pbc.26540.

MLA (9th ed.) Citation

RP, Ermoian, et al. "45 Gy Is Not Sufficient Radiotherapy Dose for Group III Orbital Embryonal Rhabdomyosarcoma After Less than Complete Response to 12 Weeks of ARST0331 Chemotherapy: A Report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group." Pediatric Blood & Cancer, vol. 64, no. 9, 2017, https://doi.org/10.1002/pbc.26540.